Institution - Queen Mary University of London
Researcher - Professor Marco Falasca
Grant award - £178,587
Duration - 2013-2016
PG12-23 Falasca

The project in a nutshell

Testing new drugs that stop a protein which is important in prostate cancer growing and spreading.

Why we funded it

The drugs being tested are looking to block the molecules that stop the body becoming resistant to current drugs. This could benefit patients who develop resistance to chemotherapy drugs and improve drug options for all men with prostate cancer.

  • For more detailed information on this project, please look at the lay summary (.docx)